Ahead of the Longevity Leaders World Congress, Cambrian’s James Peyer talks stepping stones and silver bullets in geroscience research.
Seattle-based longevity biotech YouthBio Therapeutics has emerged from stealth mode, revealing it is working on the development of “gene therapies aimed at epigenetic rejuvenation, particularly with the help of partial reprogramming by Yamanaka factors.” The company boasts some top longevity science talent, with Dr João Pedro de Magalhães serving as its chief scientific officer and Dr Alejandro Ocampo as lead research collaborator.
Longevity. Technology: Cellular reprogramming is hot, hot hot! YouthBio joins a growing list of companies, including Altos Labs, Shift Bioscience and Turn Bio, among others, all aiming to change the course of human health through this exciting, yet early stage, science. Like everyone else, we’ll be watching all the players very closely – where will the first major breakthrough come from?
Cellular reprogramming is the process by which aged cells can be returned to a pluripotent (embryonic-like) state. This process, which can be achieved using Yamanaka factors, also improves the cells’ aging hallmarks. Partial reprogramming means that Yamanaka factors are induced only for short periods, which is not enough to fully change cells beyond a point of no return but is enough to induce rejuvenation.
Loading And Transporting On Site The Caterpillar 385C Excavator – Sotiriadis/Labrianidis Mining Amazing Excavators At Work, Heavy Equipment, Heavy Machines.
A brighter future could be in store for people with a spinal cord injury if new animal research pans out in humans.
Mice that were paralyzed due to severe spinal cord damage regained the ability to walk within four weeks of receiving an experimental injectable therapy, say researchers led by Samuel Stupp of Northwestern University in Chicago.
The research team plans to seek U.S. Food and Drug Administration approval for the treatment to be used in people.
If your business needs backend services for its websites and apps, IT pros say these are the serverless computing providers to turn to.
Somnium Space is developing a way for people to talk to their loved ones even after they die. All it requires is massive amounts of personal data.
Artificial intelligence (AI) has seen increasing adoption with its use expanding into fraud detection and even the creative realm, which is commonly perceived to be intrinsically human. Humans, though, still have a role to play in areas that require intuition and morality.
Creative AI may seem to be an oxymoron, but AI-powered processes already are at work in activities that thrive on creativity, according to executives at Appier. Based in Taiwan, the SaaS vendor taps AI to build products for digital marketers and brands, processing almost 30 billion predictions a day. Its tools are touted to help these companies deliver richer user experience and identify customers with long-term value.
AI now was used to support creative processes such as generating marketing slogans, images, and music based on given parameters, said Appier’s chief AI scientist Sun Min, in an interview with ZDNet.
There are some demerits of every new technology.but remote works makes our life easier.reduces transportation cost.
With remote work, boundaries between professional and personal are blurred — and too many of us are working later than we should.
The condition stays with you for life once diagnosed, but treatments and specialists can help to manage the condition and its symptoms.
Experts are still unsure exactly what triggers the condition that affects more than 130,000 people in the UK.
According to the MS Society, people are most likely to find out they have MS in their thirties, forties and fifties in Britain, and the condition affects almost three times as many women as men.